GlassScriptPhysician profile
Whitney Bates Hope
NPI 1710496575
$1,612.60
in general payments reported to CMS, 2019-2025
24 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $508 · 2022: $302 · 2023: $262 · 2024: $276 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $301.47 | 2021-2025 | |
| Novo Nordisk INC | $224.97 | 2021-2024 | Wegovy, Ozempic |
| Lilly USA, LLC | $208.73 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Pfizer INC. | $125.16 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.74 | 2021-2024 | Synjardy, Jardiance |
| Merck Sharp & Dohme LLC | $89.83 | 2021-2025 | Verquvo, Vaxelis, Vaxneuvance |
| Astrazeneca Pharmaceuticals LP | $80.80 | 2021-2025 | Airsupra |
| Amgen INC. | $70.36 | 2022-2024 | Otezla, Repatha |
| Organon LLC | $60.56 | 2021-2025 | Nexplanon |
| Sanofi-Aventis U.S. LLC | $47.51 | 2021-2022 | |
| Daiichi Sankyo INC. | $35.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $31.34 | 2025 | |
| Eisai INC. | $27.25 | 2021 | |
| Genentech USA, INC. | $24.92 | 2021 | |
| Boston Scientific Corporation | $24.11 | 2025 | Wavewriter Alpha Prime 16 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $19.50 | 2024 | Sunosi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.52 | 2025 | Xifaxan |
| Cranial Technologies, INC | $17.91 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.47 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.25 | 2025 | Rexulti |
| Seqirus USA INC | $15.15 | 2022 | |
| Exact Sciences Corporation | $14.11 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $12.50 | 2023 | Gemtesa |
| Upsher-Smith Laboratories LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Hope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.